ARCHIVES

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds

October 29, 2010

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

ONS Scientific Program Grows

June 20, 1980

Senate Finance Reports A Reform Bill On Deadline

July 8, 1994

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010